[PMID: 4400818] PubMed record related to this compound for laboratory literature review
Neither is a reliable source of fluids when youre trying to stay hydrated, especially on a GLP-1
The incidence varies considerably between different medications and doses: Semaglutide (Ozempic): Vomiting occurs in approximately 5-10% of patients at diabetes doses Semaglutide (Wegovy): At the higher weight management dose (2.4mg), vomiting affects up to 16% of patients Liraglutide (Victoza): Vomiting affects approximately 5% of patients Liraglutide (Saxenda): At weight management doses, vomiting occurs in about 7-10% of patients Dulaglutide (Trulicity): Vomiting affects approximately 7-9% of patients Tirzepatide (Mounjaro): Vomiting occurs in approximately 5-10% of patients, varying by dose These side effects are most pronounced during the initial treatment phase, particularly in the first 48 weeks, and often diminish as the body adapts to the medication

Sin embargo, a la fecha de esta publicacin, los resultados completos no han sido publicados en una revista cientfica revisada por pares, por lo que los detalles especficos sobre la magnitud del efecto y los subgrupos beneficiados deben interpretarse con cautela hasta su publicacin formal
Ancak inslin veya baz antidiyabetik ilalarla birlikte kullanldklarnda hipoglisemi riski ortaya kabilir
Fresh ginger in stir-fries, soups, and marinades acts as a natural antiemetic